APOTEX CORP. for APOTEX CORP.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Exclusion of biologics policy from the intellectual property rights section of the Trans-Pacific Partnership
Foreign entity interest: ApoSherm Inc., the parent company of Apotex Corp., has direct or indirect interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | Legislative Director, Congressman Frank Pallone |
Copyright/Patent/Trademark CPT
H.R. 1249, the America Invents Act, Section 11, Supplemental Examination S. 23, the American Invents Act, Section 10, Supplemental Examination
Foreign entity interest: ApoSherm Inc., the parent company of Apotex Corp., has direct or indirect interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | Legislative Director, Congressman Frank Pallone |
Pharmacy PHA
S. 27, the Preserve Access to Affordable Pharmaceuticals Act Amending Section 505(j) of the Food, Drug, and Comsetic Act, concerning the ability of generic pharmaceutical manufacturers to file counterclaims seeking the correction of incorrect information submitted to FDA's Orange Book by patent owners or holders of New Drug Applications Supreme Court consideration of Novo Nordisk A/S and Novo Nordisk Inc. vs Carco Pharmaceutical Laboratories Ltd and Sun Pharmaceuticals Industries, Ltd Prospective action on legislation establishing a generic drug user fee program Prospection action on legislation establishing a biosimilar user fee program S. 296, the Preserving Access to Life Saving Medications Act Establishment of a federal track and trace system for pharmaceuticals
Foreign entity interest: ApoSherm Inc., the parent company of Apotex Corp., has direct or indirect interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | Legislative Director, Congressman Frank Pallone |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.